Skip Navigation

Europace 1999 1(4):234-241; doi:10.1053/eupc.1999.0055
© 1999 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Meurling, C.J.
Right arrow Articles by Olsson, S.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meurling, C.J.
Right arrow Articles by Olsson, S.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil

C.J. Meurling, M.P. Ingemansson, A. Roijer, J. Carlson, C.J. Lindholm, B. Smideberg, L. Sorno*, M. Stridh* and S.B. Olsson

Department of Cardiology, Lund University Lund, Sweden; *Department of Applied Electronics, Lund Institute of Technology Lund, Sweden

AIMS: Electrical remodelling with shortening of the atrial refractory period and increased fibrillatory rate occurs after onset of atrial fibrillation and can be attenuated by pre-treatment with intravenous verapamil. The aim of the present study was to investigate whether already established fibrillatory-induced shortening of atrial fibrillatory cycle length could be reversed with oral verapamil.

METHODS AND RESULTS: Thirteen patients (nine men; mean age 67 years) with chronic atrial fibrillation (CAF) were studied. The dominant atrial cycle length (DACL) was estimated non-invasively using the frequency analysis of fibrillatory ECG (FAF-ECG) method. Measurements were repeated following treatment with slow release oral verapamil. DACL increased from 147±13 ms to 156±21 ms after 1 day (P=0·02), to 164±18 ms after 5 days (P=0·005) and finally to 160±16 ms after 6 weeks (P=0·008).

CONCLUSION: Long-term oral treatment with verapamil increases the DACL significantly in patients with CAF. The prolongation is evident after 1 day and is further developed during the first 5 days of treatment. Since DACL is believed to be an index of refractoriness, the findings of the present study suggest that this treatment increases the atrial refractory period in patients with CAF.

Key Words: Atrial fibrillation, remodelling, verapamil, arrhythmia, Ca-channel

Correspondence: Dr Carl J. Meurling, Department of Cardiology, University Hospital, SE-221 85 Lund, Sweden.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Phil Trans R Soc AHome page
L. Sornmo, M. Stridh, D. Husser, A. Bollmann, and S. B. Olsson
Analysis of atrial fibrillation: from electrocardiogram signal processing to clinical management
Phil Trans R Soc A, January 28, 2009; 367(1887): 235 - 253.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
A. Bollmann, A. Tveit, D. Husser, M. Stridh, L. Sornmo, P. Smith, and S. B. Olsson
Fibrillatory rate response to candesartan in persistent atrial fibrillation
Europace, October 1, 2008; 10(10): 1138 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
S. Niwano, H. Fukaya, T. Sasaki, Y. Hatakeyama, A. Fujiki, and T. Izumi
Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring
Europace, December 1, 2007; 9(12): 1209 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
A. Bollmann, D. Husser, L. Mainardi, F. Lombardi, P. Langley, A. Murray, J. J. Rieta, J. Millet, S. B. Olsson, M. Stridh, et al.
Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications.
Europace, November 1, 2006; 8(11): 911 - 926.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Holmqvist, M. Stridh, J. E.P. Waktare, L. Sornmo, S. B. Olsson, and C. J. Meurling
Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation
Eur. Heart J., September 2, 2006; 27(18): 2201 - 2207.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
F. Holmqvist, M. Stridh, J. E.P. Waktare, A. Roijer, L. Sornmo, P. G. Platonov, and C. J. Meurling
Atrial fibrillation signal organization predicts sinus rhythm maintenance in patients undergoing cardioversion of atrial fibrillation
Europace, August 1, 2006; 8(8): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. Holmqvist, M. Stridh, J. E. P. Waktare, J. Brandt, L. Sornmo, A. Roijer, and C. J. Meurling
Rapid fluctuations in atrial fibrillatory electrophysiology detected during controlled respiration
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H754 - H760.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C-J A Lindholm, O Fredholm, S-J Moller, N Edvardsson, T Kronvall, T Pettersson, V Firsovaite, A Roijer, C J Meurling, P G Platonov, et al.
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil
Heart, May 1, 2004; 90(5): 534 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. G. Manios, E. M. Kanoupakis, G. I. Chlouverakis, M. D. Kaleboubas, H. E. Mavrakis, and P. E. Vardas
Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence
Cardiovasc Res, August 1, 2000; 47(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.